A Question of Timing: Negative Declaratory Relief in Pharmaceutical IP Practice
21 May 2021
Istanbul’s First Instance IP Court recently dismissed a negative declaratory action (the “Case”) against our client citing plaintiff’s lack of standing because the pharmaceutical at issue was unlicensed as of the when the action was started. The ruling is […]